Health Bulletin 11/November/2025
Here are the top health stories for the day:
Health Ministry Asks NMC to Review Uniform Stipend for MBBS Interns in Govt and Private Colleges
The long-pending issue of stipend disparity between the MBBS interns at the Government and Private medical colleges may soon end as the Union Ministry of Health and Family Welfare (MoHFW) has directed the National Medical Commission (NMC) to examine the possibility of paying equal stipend to all the MBBS interns of a State or Union Territory.
Bengaluru Man Arrested for Submitting Fake Medical Bills to Claim CM Relief Fund
The Bengaluru police have arrested a 59-year-old man from Nelamangala for allegedly submitting fake medical bills to claim money from the Chief Minister’s Relief Fund (CMRF).
According to the news reports, the accused, who had completed a Teacher Training Course, collected details of patients who had undergone treatment in private hospitals in Yeshwantpur. Using this information, he allegedly created fake medical papers and bills to submit fraudulent applications to the Chief Minister’s home office, under the guise of genuine medical emergencies.
For more details, check out the full story on the link mentioned below:
Bengaluru: Forged medical bills to claim CM Relief Fund, 1 arrested
Fortis Doctors Achieve Milestone by Curing Sickle Cell Disease via Bone Marrow Transplants
Doctors at Fortis Memorial Research Institute (FMRI), Gurugram, have achieved a milestone in treating children with sickle cell disease (SCD) through bone marrow (stem cell) transplantation, reporting an overall survival rate of nearly 87%. Their decade-long study, published in the international journal Haemoglobin, analysed 100 pediatric cases treated between 2015 and 2024. Matched sibling donor transplants showed a 96% success rate, while half-matched family donor transplants achieved 78%. These outcomes rank among the best globally and mark significant progress in managing sickle cell disease in developing countries.
Sickle cell disease is a debilitating inherited blood disorder causing severe anaemia, recurrent pain, organ damage, and reduced life expectancy, particularly affecting India and sub-Saharan Africa. The study underscored the importance of early diagnosis and timely transplantation, showing that performing the procedure before severe complications drastically improves survival. Fortis employed advanced protocols to reduce side effects and minimise graft-versus-host disease risk. Doctors noted that many children previously dependent on transfusions are now healthy and active, highlighting the potential for curative treatment in resource-limited settings and heralding a new era for pediatric sickle cell disease care in India and beyond.
REFERENCE: Bhayana, S., Chakaroborty, S., Nathany, S., Danewa, A., Arora, S., Pal Singh, P., … Dua, V. (2025). Encouraging Outcomes of Hematopoeitic Stem Cell Transplantation in Pediatric Sickle Cell Disease- A Decade-Long Experience from the Developing World. Hemoglobin, 49(5), 317–322. https://doi.org/10.1080/03630269.2025.2568129
AIIMS INI CET January 2026 Exam Draws Mixed Reactions, Candidates Find It Moderately Difficult
The All India Institute of Medical Sciences (AIIMS) New Delhi, conducted the INI CET January 2026 exam on Sunday i.e. November 9, 2025, at more than 130 test cities.
AIIMS will release the INI-CET results on November 15, 2025. Meanwhile, according to the aspirants who appeared in the postgraduate medical entrance test at Institutes of National Importance (INIs), the question paper for the INI CET exam was moderately difficult.
For more details, check out the full story on the link mentioned below:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.